应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
APTX Aptinyx Inc.
已收盘 11-19 16:00:00 EST 延时
资讯
新帖
简况
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 股价大涨7.45%报0.093美元
自选股智能写手 · 2023-12-28
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 股价大涨7.45%报0.093美元
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 大幅下跌6.99%报0.087美元
自选股智能写手 · 2023-12-28
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 大幅下跌6.99%报0.087美元
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大跌5.05%
自选股智能写手 · 2023-12-26
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大跌5.05%
美国OTC市场Aptinyx Inc（APTX.us）股价重挫39.59% 市值跌7.01万美元
自选股智能写手 · 2023-12-22
美国OTC市场Aptinyx Inc（APTX.us）股价重挫39.59% 市值跌7.01万美元
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 股价大跌9.57%
自选股智能写手 · 2023-12-21
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 股价大跌9.57%
美国OTC市场Aptinyx Inc（APTX.us）股价拉升41.07% 市值涨250.28万美元
自选股智能写手 · 2023-12-19
美国OTC市场Aptinyx Inc（APTX.us）股价拉升41.07% 市值涨250.28万美元
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨9.02%
自选股智能写手 · 2023-12-13
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨9.02%
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘急速拉升5.97%
自选股智能写手 · 2023-12-08
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘急速拉升5.97%
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 急速拉升5.97%报0.066美元
自选股智能写手 · 2023-12-07
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 急速拉升5.97%报0.066美元
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨5.97%报0.066美元
自选股智能写手 · 2023-12-06
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨5.97%报0.066美元
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘快速跳水5.63%
自选股智能写手 · 2023-12-05
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘快速跳水5.63%
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘急速跳水7.69%
自选股智能写手 · 2023-12-04
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘急速跳水7.69%
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 股价大涨5.97%
自选股智能写手 · 2023-12-02
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 股价大涨5.97%
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 快速下挫7.69%
自选股智能写手 · 2023-11-29
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 快速下挫7.69%
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨5.98%报0.062美元
自选股智能写手 · 2023-11-08
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨5.98%报0.062美元
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨12.00%报0.056美元
自选股智能写手 · 2023-11-07
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨12.00%报0.056美元
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大跌16.67%报0.050美元
自选股智能写手 · 2023-11-06
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大跌16.67%报0.050美元
美国OTC市场Aptinyx Inc（APTX.us）股价重挫11.29% 市值跌6.65万美元
自选股智能写手 · 2023-11-04
美国OTC市场Aptinyx Inc（APTX.us）股价重挫11.29% 市值跌6.65万美元
美国OTC市场Aptinyx Inc（APTX.us）股价上涨16.93% 市值涨85.12万美元
自选股智能写手 · 2023-11-01
美国OTC市场Aptinyx Inc（APTX.us）股价上涨16.93% 市值涨85.12万美元
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 下午盘股价大涨6.56%报0.065美元
自选股智能写手 · 2023-10-24
美国OTC市场Aptinyx Inc（APTX.us）盘中异动 下午盘股价大涨6.56%报0.065美元
加载更多
公司概况
公司名称：
Aptinyx Inc.
所属市场：
EXPERT
上市日期：
--
主营业务：
Aptinyx Inc.于2015年6月24日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于治疗大脑和神经系统疾病的新型专有合成小分子的发现，开发和商业化。该公司致力于靶向和调节N-甲基-D-天冬氨酸受体或NMDArs，NMDArs对大脑和神经系统的正常和有效功能至关重要。
发行价格：
--
{"stockData":{"symbol":"APTX","market":"US","secType":"STK","nameCN":"Aptinyx Inc.","latestPrice":0.096,"timestamp":1732050000000,"preClose":0.096,"halted":0,"volume":0,"delay":15,"floatShares":58781854,"shares":67715718,"eps":-0.975958,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"11-19 16:00:00 EST 延时","open":0.096,"high":0.096,"low":0.096,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.975958,"exchange":"EXPERT","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732093200000},"adr":0,"adjPreClose":0.096,"volumeRatio":0},"requestUrl":"/m/hq/s/APTX","defaultTab":"news","newsList":[{"id":"2394746352","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 股价大涨7.45%报0.093美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2394746352","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2394746352?lang=zh_cn&edition=full","pubTime":"2023-12-28 22:46","pubTimestamp":1703774763,"startTime":"0","endTime":"0","summary":"北京时间2023年12月28日22时46分，美国OTC市场Aptinyx Inc股票出现异动，股价大幅拉升7.45%。截至发稿，该股报0.093美元/股，成交量4122股，换手率0.01%，振幅0.00%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体涨幅为0.76%。美国OTC市场Aptinyx Inc公司简介：Aptinyx Inc. is a clinical stage biopharmaceutical company. It is discovering and developing transformative therapies for disorders of the brain and nervous system. The company was founded by Norbert G. Riedel and Joseph R. Moskal and is headquartered in Evanston, IL.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122822460381842ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122822460381842ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APTX"],"gpt_icon":0},{"id":"2394756552","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 大幅下跌6.99%报0.087美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2394756552","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2394756552?lang=zh_cn&edition=full","pubTime":"2023-12-28 04:50","pubTimestamp":1703710214,"startTime":"0","endTime":"0","summary":"北京时间2023年12月28日04时50分，美国OTC市场Aptinyx Inc股票出现波动，股价大幅下跌6.99%。截至发稿，该股报0.087美元/股，成交量10.8709万股，换手率0.16%，振幅2.15%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体涨幅为1.55%。美国OTC市场Aptinyx Inc公司简介：Aptinyx Inc. is a clinical stage biopharmaceutical company. It is discovering and developing transformative therapies for disorders of the brain and nervous system. The company was founded by Norbert G. Riedel and Joseph R. Moskal and is headquartered in Evanston, IL.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122804501479045aec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122804501479045aec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2394247376","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2394247376","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2394247376?lang=zh_cn&edition=full","pubTime":"2023-12-26 22:51","pubTimestamp":1703602265,"startTime":"0","endTime":"0","summary":"北京时间2023年12月26日22时51分，美国OTC市场Aptinyx Inc股票出现异动，股价急速下挫5.05%。截至发稿，该股报0.090美元/股，成交量416股，换手率0.00%，振幅0.00%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体涨幅为0.09%。美国OTC市场Aptinyx Inc公司简介：Aptinyx Inc. is a clinical stage biopharmaceutical company. It is discovering and developing transformative therapies for disorders of the brain and nervous system. The company was founded by Norbert G. Riedel and Joseph R. Moskal and is headquartered in Evanston, IL.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231226225105861c6d5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231226225105861c6d5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2393341309","title":"美国OTC市场Aptinyx Inc（APTX.us）股价重挫39.59% 市值跌7.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393341309","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2393341309?lang=zh_cn&edition=full","pubTime":"2023-12-22 23:25","pubTimestamp":1703258736,"startTime":"0","endTime":"0","summary":"北京时间2023年12月22日23时25分，美国OTC市场Aptinyx Inc股票出现异动，股价大幅下挫39.59%。截至发稿，该股报0.055美元/股，成交量400股，换手率0.00%，振幅0.00%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体涨幅为1.48%。美国OTC市场Aptinyx Inc公司简介：Aptinyx Inc. is a clinical stage biopharmaceutical company. It is discovering and developing transformative therapies for disorders of the brain and nervous system. The company was founded by Norbert G. Riedel and Joseph R. Moskal and is headquartered in Evanston, IL.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231222232537861c67d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231222232537861c67d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APTX"],"gpt_icon":0},{"id":"2393115285","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 股价大跌9.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2393115285","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2393115285?lang=zh_cn&edition=full","pubTime":"2023-12-21 01:41","pubTimestamp":1703094090,"startTime":"0","endTime":"0","summary":"北京时间2023年12月21日01时41分，美国OTC市场Aptinyx Inc股票出现异动，股价急速跳水9.57%。截至发稿，该股报0.085美元/股，成交量59.7295万股，换手率0.88%，振幅1.60%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体跌幅为0.65%。美国OTC市场Aptinyx Inc公司简介：Aptinyx Inc. is a clinical stage biopharmaceutical company. It is discovering and developing transformative therapies for disorders of the brain and nervous system. The company was founded by Norbert G. Riedel and Joseph R. Moskal and is headquartered in Evanston, IL.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231221014130861c5deb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231221014130861c5deb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2392356904","title":"美国OTC市场Aptinyx Inc（APTX.us）股价拉升41.07% 市值涨250.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2392356904","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2392356904?lang=zh_cn&edition=full","pubTime":"2023-12-19 22:46","pubTimestamp":1702997161,"startTime":"0","endTime":"0","summary":"北京时间2023年12月19日22时46分，美国OTC市场Aptinyx Inc股票出现波动，股价大幅拉升41.07%。截至发稿，该股报0.090美元/股，成交量25.3338万股，换手率0.37%，振幅0.00%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体涨幅为0.09%。美国OTC市场Aptinyx Inc公司简介：Aptinyx Inc. is a clinical stage biopharmaceutical company. It is discovering and developing transformative therapies for disorders of the brain and nervous system. The company was founded by Norbert G. Riedel and Joseph R. Moskal and is headquartered in Evanston, IL.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312192246028262275b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312192246028262275b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2391719053","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨9.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2391719053","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2391719053?lang=zh_cn&edition=full","pubTime":"2023-12-13 00:20","pubTimestamp":1702398016,"startTime":"0","endTime":"0","summary":"北京时间2023年12月13日00时20分，美国OTC市场Aptinyx Inc股票出现异动，股价大幅上涨9.02%。截至发稿，该股报0.067美元/股，成交量500股，换手率0.00%，振幅0.00%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体涨幅为0.23%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231213002016861c4a31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231213002016861c4a31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APTX"],"gpt_icon":0},{"id":"2389863005","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘急速拉升5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2389863005","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2389863005?lang=zh_cn&edition=full","pubTime":"2023-12-08 23:43","pubTimestamp":1702050182,"startTime":"0","endTime":"0","summary":"北京时间2023年12月08日23时43分，美国OTC市场Aptinyx Inc股票出现异动，股价大幅上涨5.97%。截至发稿，该股报0.066美元/股，成交量2085股，换手率0.00%，振幅5.97%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体跌幅为0.61%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120823430283e48a42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120823430283e48a42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APTX"],"gpt_icon":0},{"id":"2389402107","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 急速拉升5.97%报0.066美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2389402107","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2389402107?lang=zh_cn&edition=full","pubTime":"2023-12-07 22:46","pubTimestamp":1701960361,"startTime":"0","endTime":"0","summary":"北京时间2023年12月07日22时46分，美国OTC市场Aptinyx Inc股票出现波动，股价大幅拉升5.97%。截至发稿，该股报0.066美元/股，成交量105股，换手率0.00%，振幅0.00%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体跌幅为0.36%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231207224601823aa84c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231207224601823aa84c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2389059354","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨5.97%报0.066美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2389059354","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2389059354?lang=zh_cn&edition=full","pubTime":"2023-12-06 23:13","pubTimestamp":1701875580,"startTime":"0","endTime":"0","summary":"北京时间2023年12月06日23时13分，美国OTC市场Aptinyx Inc股票出现异动，股价快速拉升5.97%。截至发稿，该股报0.066美元/股，成交量3252股，换手率0.00%，振幅5.97%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体涨幅为0.59%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120623130082361115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120623130082361115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APTX"],"gpt_icon":0},{"id":"2389725456","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘快速跳水5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2389725456","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2389725456?lang=zh_cn&edition=full","pubTime":"2023-12-05 23:27","pubTimestamp":1701790021,"startTime":"0","endTime":"0","summary":"北京时间2023年12月05日23时27分，美国OTC市场Aptinyx Inc股票出现波动，股价急速跳水5.63%。截至发稿，该股报0.062美元/股，成交量904股，换手率0.00%，振幅5.63%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体跌幅为0.55%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120523270183d47e3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120523270183d47e3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2388275399","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘急速跳水7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2388275399","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2388275399?lang=zh_cn&edition=full","pubTime":"2023-12-04 23:04","pubTimestamp":1701702273,"startTime":"0","endTime":"0","summary":"北京时间2023年12月04日23时04分，美国OTC市场Aptinyx Inc股票出现波动，股价大幅下跌7.69%。截至发稿，该股报0.060美元/股，成交量1.8981万股，换手率0.03%，振幅5.69%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体跌幅为0.32%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120423043483a2613a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120423043483a2613a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2388256097","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 股价大涨5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2388256097","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2388256097?lang=zh_cn&edition=full","pubTime":"2023-12-02 00:01","pubTimestamp":1701446461,"startTime":"0","endTime":"0","summary":"北京时间2023年12月02日00时01分，美国OTC市场Aptinyx Inc股票出现异动，股价急速上涨5.97%。截至发稿，该股报0.066美元/股，成交量722股，换手率0.00%，振幅5.97%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体跌幅为0.23%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120200010183c55415&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120200010183c55415&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2387565128","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 快速下挫7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2387565128","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2387565128?lang=zh_cn&edition=full","pubTime":"2023-11-29 02:01","pubTimestamp":1701194461,"startTime":"0","endTime":"0","summary":"北京时间2023年11月29日02时01分，美国OTC市场Aptinyx Inc股票出现异动，股价大幅下跌7.69%。截至发稿，该股报0.060美元/股，成交量5.3953万股，换手率0.08%，振幅7.69%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体跌幅为1.54%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231129020101844f1b0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231129020101844f1b0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APTX"],"gpt_icon":0},{"id":"2381288727","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨5.98%报0.062美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2381288727","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2381288727?lang=zh_cn&edition=full","pubTime":"2023-11-08 22:46","pubTimestamp":1699454763,"startTime":"0","endTime":"0","summary":"北京时间2023年11月08日22时46分，美国OTC市场Aptinyx Inc股票出现波动，股价大幅上涨5.98%。截至发稿，该股报0.062美元/股，成交量1100股，换手率0.00%，振幅0.00%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体跌幅为0.10%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。其主要产品为NYX-2925，NYX-458和NYX-783。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231108224603825aff06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231108224603825aff06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2381468494","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大涨12.00%报0.056美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2381468494","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2381468494?lang=zh_cn&edition=full","pubTime":"2023-11-07 22:46","pubTimestamp":1699368361,"startTime":"0","endTime":"0","summary":"北京时间2023年11月07日22时46分，美国OTC市场Aptinyx Inc股票出现异动，股价急速上涨12.00%。截至发稿，该股报0.056美元/股，成交量2496股，换手率0.00%，振幅12.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体跌幅为0.73%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231107224601825655b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231107224601825655b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2381840105","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 早盘股价大跌16.67%报0.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2381840105","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2381840105?lang=zh_cn&edition=full","pubTime":"2023-11-06 22:46","pubTimestamp":1699281963,"startTime":"0","endTime":"0","summary":"北京时间2023年11月06日22时46分，美国OTC市场Aptinyx Inc股票出现异动，股价大幅下挫16.67%。截至发稿，该股报0.050美元/股，成交量200股，换手率0.00%，振幅0.00%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体涨幅为1.10%。美国OTC市场Aptinyx Inc公司简介：Aptinyx是一家临床阶段的生物制药公司，致力于新型专有合成小分子的开发和商业化，用于治疗脑部和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231106224603825185a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231106224603825185a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APTX"],"gpt_icon":0},{"id":"2380902617","title":"美国OTC市场Aptinyx Inc（APTX.us）股价重挫11.29% 市值跌6.65万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2380902617","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2380902617?lang=zh_cn&edition=full","pubTime":"2023-11-04 02:17","pubTimestamp":1699035461,"startTime":"0","endTime":"0","summary":"北京时间2023年11月04日02时17分，美国OTC市场Aptinyx Inc股票出现波动，股价急速下跌11.29%。截至发稿，该股报0.055美元/股，成交量3.321万股，换手率0.05%，振幅2.42%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体涨幅为0.18%。美国OTC市场Aptinyx Inc公司简介：Aptinyx Inc. is a clinical stage biopharmaceutical company. It is discovering and developing transformative therapies for disorders of the brain and nervous system. The company was founded by Norbert G. Riedel and Joseph R. Moskal and is headquartered in Evanston, IL.（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311040217418301d8c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311040217418301d8c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2380520981","title":"美国OTC市场Aptinyx Inc（APTX.us）股价上涨16.93% 市值涨85.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2380520981","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2380520981?lang=zh_cn&edition=full","pubTime":"2023-11-01 02:59","pubTimestamp":1698778742,"startTime":"0","endTime":"0","summary":"北京时间2023年11月01日02时59分，美国OTC市场Aptinyx Inc股票出现波动，股价急速上涨16.93%。截至发稿，该股报0.074美元/股，成交量2518股，换手率0.00%，振幅16.93%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体涨幅为0.42%。美国OTC市场Aptinyx Inc公司简介：Aptinyx Inc. is a clinical stage biopharmaceutical company. It is discovering and developing transformative therapies for disorders of the brain and nervous system. The company was founded by Norbert G. Riedel and Joseph R. Moskal and is headquartered in Evanston, IL.（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311010259028398b361&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311010259028398b361&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0},{"id":"2377743374","title":"美国OTC市场Aptinyx Inc（APTX.us）盘中异动 下午盘股价大涨6.56%报0.065美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2377743374","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2377743374?lang=zh_cn&edition=full","pubTime":"2023-10-24 01:51","pubTimestamp":1698083504,"startTime":"0","endTime":"0","summary":"北京时间2023年10月24日01时51分，美国OTC市场Aptinyx Inc股票出现异动，股价大幅上涨6.56%。截至发稿，该股报0.065美元/股，成交量4.4726万股，换手率0.07%，振幅1.64%。美国OTC市场Aptinyx Inc股票所在的生物技术行业中，整体跌幅为0.15%。美国OTC市场Aptinyx Inc公司简介：Aptinyx Inc. is a clinical stage biopharmaceutical company. It is discovering and developing transformative therapies for disorders of the brain and nervous system. The company was founded by Norbert G. Riedel and Joseph R. Moskal and is headquartered in Evanston, IL.（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202310240151448475e2ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202310240151448475e2ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APTX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aptinyx.com","description":"Aptinyx Inc.于2015年6月24日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于治疗大脑和神经系统疾病的新型专有合成小分子的发现，开发和商业化。该公司致力于靶向和调节N-甲基-D-天冬氨酸受体或NMDArs，NMDArs对大脑和神经系统的正常和有效功能至关重要。","exchange":"EXPERT","name":"Aptinyx Inc.","nameEN":"Aptinyx Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aptinyx Inc.(APTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aptinyx Inc.(APTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aptinyx Inc.,APTX,Aptinyx Inc.股票,Aptinyx Inc.股票老虎,Aptinyx Inc.股票老虎国际,Aptinyx Inc.行情,Aptinyx Inc.股票行情,Aptinyx Inc.股价,Aptinyx Inc.股市,Aptinyx Inc.股票价格,Aptinyx Inc.股票交易,Aptinyx Inc.股票购买,Aptinyx Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aptinyx Inc.(APTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aptinyx Inc.(APTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}